Beaten Down Safe Stocks to Buy Now in Market Crash? Strong Fundamentals! Dipan Mehta

Market context & decision framework

• Markets are volatile; the presenter said the market has fallen roughly 13% from its peak.
• Two explicit signals to watch before “buying the dip”:
  1. Crude oil price: a fall in Brent/WTI below about $80 per barrel would be a constructive signal for Indian equities (India is highly vulnerable to oil spikes because of imports, pass-through to inflation, government subsidies/pricing and sentiment).
  2. Market technicals: confirmation of a trend reversal in Nifty/Sensex showing higher highs and higher lows (instead of recent lower highs/lower lows).
• Caution: if oil stays high long-term, the government may raise petrol/diesel prices, which would change the macro outlook.

Stocks / sectors mentioned (finance-relevant)

• Oil marketing companies (OMCs) / crude oil exposure
  • HPCL (Hindustan Petroleum Corporation Ltd) — oil marketing & refining
• Beverages / bottlers
  • Varun Beverages (Pepsi bottler)
• Banks / PSU banks
  • Canara Bank (example of attractive PSU bank)
• Pharmaceuticals (complex injectables / export-oriented)
  • Gland Pharma
• Solar equipment / renewables manufacturing
  • Vikram Solar

Ideas — key facts, metrics, rationale, caveats

1) HPCL (Oil marketing + refining)

• Rationale
  • OMCs’ marketing margins compress when crude rises due to government-controlled retail pricing; they rebound when oil falls.
  • HPCL is positioned to benefit from lower oil and from planned refinery-capacity expansion.
• Key numbers cited
  • Dividend yield: ≈ 3%.
  • Recent quarter sales of refined products: ≈ 13.5 million metric tonnes.
  • Own refinery output: ≈ 6.7 million tonnes (about half of sales).
  • Refining capacity: expected to rise from ~35 mt to ~45 mt over ~2 years.
  • P/E cited: ≈ 5x.
  • Market cap cited: ≈ Rs 74,000 crore.
• Risks / notes
  • Current negative marketing margins due to government pricing; possible government compensation later.
  • Business is cyclical and tied to oil-price movements.
• Disclosure
  • Presenter repeatedly: “not a recommendation — do your own research.”

2) Varun Beverages (Pepsi bottler)

• Rationale
  • High-seasonality upside if summer is very hot (El Niño scenario expected).
  • International expansion (Africa) and new alliances (beer bottling tie-up).
  • Historically strong management performance.
• Key numbers / metrics
  • Prior-year volume growth: ≈ 10% (described as “soft”).
  • Valuation: presenter said “about 47x” but phrasing was ambiguous (may be a discount to its 4‑year average). Verify independently.
• Risks / notes
  • Significant past run-up (multibagger); watch valuation.
  • Growth depends on normalization and strong summer demand.

3) Canara Bank (PSU bank example)

• Rationale
  • PSU banks have cleaned up balance sheets after government recapitalization and reforms.
  • Some PSU banks now showing credit growth and asset-quality metrics comparable to large private banks.
• Key numbers cited
  • Advances and deposits growth: ≈ 13–14% in the last quarter (vs. ~10–11% for HDFC Bank, as cited).
  • Net bad loans / net NPA: speaker said “45%” which is ambiguous (likely a transcription error — verify; could mean 0.45% or similar).
  • P/E cited: ≈ 6.25x.
  • Dividend yield: ≈ 3%.
• Rationale (value angle)
  • Low multiple vs private banks; potential re-rating if earnings/credit momentum continues.
• Risks / notes
  • Historically weaker operational metrics vs private banks.
  • Still sensitive to macro and credit cycles.

4) Gland Pharma (complex injectables)

• Rationale
  • Focused on complex injectable products and heavy exposure to the US market.
  • Higher technology / barrier-to-entry versus simple generics.
  • Potential opportunity from off‑patent biologic/weight‑loss drugs (semaglutide/Ozempic/Wegovy) as generics/alternate suppliers emerge.
• Key numbers
  • December quarter: revenue growth ≈ 22.5%; net profit growth ≈ 36%.
  • P/E cited: ≈ 31x.
• Risks / notes
  • Company had weak performance in recent years; management has taken remedial steps.
  • Business model differs from typical Indian generics players.

5) Vikram Solar (solar cell/module manufacturing)

• Rationale
  • Market leader in solar cells/modules with recent capacity expansion and backward integration to cells.
  • Strong order book and export potential if trade/tariff issues settle.
  • Renewables get investor attention due to energy security concerns.
• Key numbers
  • Capacity: doubled (Dec) from ~4.5–5 GW to ~9 GW; target ~12–13 GW in 2–3 years.
  • Dec quarter: revenue up ≈ 78%, profit up ≈ 436% (large margin expansion cited).
  • Export share: ≈ 20% of revenue.
  • P/E cited: ≈ 15.42x.
  • Stock down ≈ 52% from all-time high.
  • Technology mention: presenter referenced “TOPCon” (verify).
• Risks / notes
  • Competition and tariffs (e.g., US tariffs on modules) affect export access and sentiment.
  • Geopolitics and trade policy are material risks.

Methodology / step-by-step frameworks shared

• Two-factor buy-dip signal
  1. Macro input: oil price falls below ~$80 → positive for India equities/OMCs.
  2. Technical market confirmation: Nifty/Sensex form higher highs and higher lows.
• Stock selection filters (implied)
  • Blue‑chip / large‑cap companies with strong governance and track record.
  • Exposure to cyclical recovery catalysts (seasonality, oil‑price normalization).
  • Structural capacity additions or margin drivers (refining capacity, manufacturing/backward integration).
  • Export levers and product complexity (pharma injectables, solar tech).
  • Valuation gaps (low P/E or large drawdown from ATHs).
• Portfolio guidance
  • Improve portfolio quality even if fully invested.
  • Not bottom‑fishing — wait for the bottom or confirmatory signals.

Macro & risk points to watch

• Oil price movements (impact on inflation, government subsidy burden, OMC margins).
• Government pricing and potential compensation for OMCs if margins are negative.
• Trade/tariff environment (US tariffs on solar modules).
• Seasonality (El Niño / hot summer boosting beverage demand).
• Bank asset quality and credit growth trends.

Explicit numbers & timeline highlights (quick list)

• Market down: ≈ 13% from top.
• Oil trigger: $80 per barrel cited as threshold to consider deploying cash.
• HPCL
  • Dividend ≈ 3%; refined products sold ≈ 13.5 mt; own output ≈ 6.7 mt.
  • Capacity: 35 → 45 mt in ~2 years.
  • P/E ≈ 5x; market cap ≈ Rs 74,000 crore.
• Varun Beverages
  • Prior-year volume growth ≈ 10%; valuation figure mentioned ≈ 47x (ambiguous).
• Canara Bank
  • Advances/deposits growth ≈ 13–14% last quarter; P/E ≈ 6.25x; dividend ≈ 3%.
  • Net NPA figure spoken as “45%” (ambiguous — verify).
• Gland Pharma
  • Dec quarter revenue +22.5%; net profit +36%; P/E ≈ 31x.
• Vikram Solar
  • Capacity: ~4.5–5 GW → 9 GW (Dec); planned 12–13 GW in 2–3 years.
  • Exports ≈ 20% of revenue.
  • Dec quarter revenue +78%, profit +436%; P/E ≈ 15.42x.
  • Stock down ~52% from ATH.

Disclosures / disclaimers called out in the video

“This is not a recommendation / not financial advice — do your own research.”

• The channel mentions being a Registered Research Analyst and provides registration number INA004787.
• Information presented is described as educational; investors should read carefully before investing.

Presenters / sources

• Paisa channel (YouTube).
• Guest / presenter repeatedly named: Dipan / Deepan Mehta (introduced as “Director at Alex” in the transcript).
• Internal references: trading team and a model portfolio offered by the channel (QR code referenced).

Notes & verification flags

• Some numeric phrases in the transcript/subtitles are ambiguous or likely transcription errors (e.g., “net MPA 45%,” Varun’s “47 times” valuation phrasing).
• Verify all quoted ratios, NPAs and multiples against company filings or broker reports before acting.